Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Inari Medical, Inc. NARI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
40/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$67.56
-15.5%

Inari Medical, Inc. (NARI) is a Medical - Devices company in the Healthcare sector, currently trading at $79.97. It has a SharesGrow Score of 40/100, indicating a mixed investment profile with 0 out of 7 criteria passed.

Analyst consensus target is NARI = $68 (-15.5% upside).

Financials: revenue is $494M, +55.2%/yr average growth. Net income is $2M (loss), growing at -110.6%/yr. Net profit margin is -0.3% (negative). Gross margin is 88% (-2.6 pp trend).

Balance sheet: total debt is $32M against $465M equity (Debt-to-Equity (D/E) ratio 0.07, conservative). Current ratio is 3.09 (strong liquidity). Debt-to-assets is 4.8%. Total assets: $674M.

Analyst outlook: 4 / 12 analysts rate NARI as buy (33%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 20/100 (Fail), Growth 58/100 (Partial), Past 50/100 (Partial), Health 67/100 (Partial), Moat 61/100 (Partial), Future 16/100 (Fail), Income 10/100 (Fail).

$67.56
▼ 15.52% Downside
Average Price Target
Based on 12 Wall Street analysts offering 12-month price targets for Inari Medical, Inc., the average price target is $67.56, with a high forecast of $86.00, and a low forecast of $50.00.
Highest Price Target
$86.00
Average Price Target
$67.56
Lowest Price Target
$50.00

NARI SharesGrow Score Overview

40/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 20/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 61/100
Gross margin is + market cap
FUTURE 16/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — NARI

✗
VALUE Fail
20/100
NARI trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $68, implying -15% from the current price $80. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
NARI: +55.2%/yr revenue is, -110.6%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
NARI: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet NARI: Debt-to-Equity (D/E) ratio 0.07 (conservative), Current ratio is 3.09 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
61/100
NARI: Gross margin is 88% (-2.6 pp trend), $5B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 61/100. ≥ 70 = Pass.
View details →
✗
FUTURE Fail
16/100
Analyst outlook: 4 / 12 analysts rate NARI as buy (33%). Analyst consensus target is $68 (-15% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
NARI: Net profit margin is -0.3%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range36.73-79.99
Volume2.36M
Avg Volume (30D)2.44M
Market Cap$4.68B
Beta (1Y)1.03
Share Statistics
EPS (TTM)-0.03
Shares Outstanding$56.77M
IPO Date2020-05-22
Employees1,300
CEOKevin Strange
Financial Highlights & Ratios
Revenue (TTM)$493.63M
Gross Profit$434.56M
EBITDA$15.19M
Net Income$-1.64M
Operating Income$-14.03M
Total Cash$115.45M
Total Debt$32.05M
Net Debt$-6.55M
Total Assets$674.24M
Price / Earnings (P/E)-2776.7
Price / Sales (P/S)9.49
Analyst Forecast
1Y Price Target$67.00
Target High$86.00
Target Low$50.00
Upside-16.2%
Rating ConsensusHold
Analysts Covering12
Buy 33% Hold 67% Sell 0%
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS45332Y1091

Price Chart

Track all markets on TradingView
NARI
Inari Medical, Inc. ↗  ·  NASDAQ Global Select
Healthcare • Medical - Devices
36.73 52WK RANGE 79.99

People Also View

SWAV
SWAV
ShockWave Medical, Inc.
$334.75
-0.02%
 AXNX
AXNX
Axonics, Inc.
$70.98
+0.00%
 LEGN
LEGN
Legend Biotech Corporation
$18.69
+5.65%
 PGNY
PGNY
Progyny, Inc.
$17.17
+1.12%
 OM
OM
Outset Medical, Inc.
$4.35
+0.93%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message